843 related articles for article (PubMed ID: 34588751)
1. Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity.
Wei YX; Zheng KY; Wang YG
World J Gastroenterol; 2021 Sep; 27(33):5555-5565. PubMed ID: 34588751
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity.
Gasmi A; Mujawdiya PK; Pivina L; Doşa A; Semenova Y; Benahmed AG; Bjørklund G
Curr Med Chem; 2021; 28(4):827-839. PubMed ID: 32693755
[TBL] [Abstract][Full Text] [Related]
4. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
5. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis.
Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E
Front Immunol; 2021; 12():635704. PubMed ID: 34054805
[TBL] [Abstract][Full Text] [Related]
7. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health.
Lamas B; Martins Breyner N; Houdeau E
Part Fibre Toxicol; 2020 Jun; 17(1):19. PubMed ID: 32487227
[TBL] [Abstract][Full Text] [Related]
8. Does an Apple a Day Also Keep the Microbes Away? The Interplay Between Diet, Microbiota, and Host Defense Peptides at the Intestinal Mucosal Barrier.
Puértolas-Balint F; Schroeder BO
Front Immunol; 2020; 11():1164. PubMed ID: 32655555
[TBL] [Abstract][Full Text] [Related]
9. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice.
Ma L; Ni Y; Wang Z; Tu W; Ni L; Zhuge F; Zheng A; Hu L; Zhao Y; Zheng L; Fu Z
Gut Microbes; 2020 Nov; 12(1):1-19. PubMed ID: 33151120
[TBL] [Abstract][Full Text] [Related]
10. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
Lin L; Zhang J
BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
[TBL] [Abstract][Full Text] [Related]
11. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
Yu Y; Yang W; Li Y; Cong Y
Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
[TBL] [Abstract][Full Text] [Related]
12. An overview of traditional Chinese medicine affecting gut microbiota in obesity.
Li D; Tang W; Wang Y; Gao Q; Zhang H; Zhang Y; Wang Y; Yang Y; Zhou Y; Zhang Y; Li H; Li S; Zhao H
Front Endocrinol (Lausanne); 2023; 14():1149751. PubMed ID: 36936157
[TBL] [Abstract][Full Text] [Related]
13. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
14. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
Shamoon M; Martin NM; O'Brien CL
Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
[TBL] [Abstract][Full Text] [Related]
17. Role of the gut microbiota in type 2 diabetes and related diseases.
Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
19. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis.
Nagai M; Obata Y; Takahashi D; Hase K
Int Immunopharmacol; 2016 Aug; 37():79-86. PubMed ID: 27133028
[TBL] [Abstract][Full Text] [Related]
20. Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection.
Wang C; Li Q; Ren J
Front Immunol; 2019; 10():1873. PubMed ID: 31456801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
